Skip to main content

Research Repository

Advanced Search

Outputs (32)

786 CHALLENGES OF IMPLEMENTING A NEW MODEL OF CARE FOR OSTEOARTHRITIS AMONG COMMUNITY PHARMACIES IN SOUTH-WESTERN NIGERIA: Focus on the Joint Implementation of Guidelines for OSteoArthritis in West-Africa (JIGSAW-A). (2024)
Presentation / Conference
Adetunji, O. A., Owoyemi, T., Alonge, I., Ogunbanjo, A., Taiwo, P., Carter, J., …Babatunde, O. O. (2024, April). 786 CHALLENGES OF IMPLEMENTING A NEW MODEL OF CARE FOR OSTEOARTHRITIS AMONG COMMUNITY PHARMACIES IN SOUTH-WESTERN NIGERIA: Focus on the Joint Implementation of Guidelines for OSteoArthritis in West-Africa (JIGSAW-A). Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

768 STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL (2024)
Presentation / Conference
Holden, M., Stanford, C., Simkins, J., Babatunde, O. O., White, S., O'Brien, N., …Healey, E. L. (2024, April). 768 STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

767 EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE PROFESSIONALS (2024)
Presentation / Conference
Simkins, J., Holden, M., Babatunde, O. O., White, S., Nicholls, E., Long, A., …O'Brien, N. (2024, April). 767 EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE PROFESSIONALS. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis (2024)
Presentation / Conference
Cunningham, J. C., Briggs, A. M., Cottrell, E., Doyle, F., Dziedzic, K., Finney, A., …French, H. (2024, April). 306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria

Protocol for the development and validation of a Rheumatoid Arthritis PredIction moDel using primary care health records (RAPID) (2024)
Working Paper
Hammond, B., Baranskaya, A., Adderley, N., Zemedikun, D., d’Elia, A., Falahee, M., …Raza, K. Protocol for the development and validation of a Rheumatoid Arthritis PredIction moDel using primary care health records (RAPID)

Background Rheumatoid Arthritis (RA) is a chronic rheumatological condition which causes inflammation of both the joint lining and extra-articular sites. It affects around 1% of the UK population and, if not properly treated, can lead joint damage, d... Read More about Protocol for the development and validation of a Rheumatoid Arthritis PredIction moDel using primary care health records (RAPID).

Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. (2024)
Journal Article
Muller, S., Bailey, J., Bajpai, R., Helliwell, T., Harrisson, S. A., Whittle, R., …Ashworth, J. (in press). Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study. PAIN, https://doi.org/10.1097/j.pain.0000000000003239

Growing evidence from pharmacovigilance data and postmortem toxicology reports highlights the misuse potential of gabapentinoids. This study aimed to investigate the risk of serious adverse outcomes (drug misuse, overdose, major trauma), and their ri... Read More about Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study..

An evaluation of a public partnership project between academic institutions and young people with Black African, Asian and Caribbean heritage (2024)
Journal Article
Moult, A., Knight, N., Medina, N., Babatunde, O., Kingstone, T., Duffy, H., …Dziedzic, K. (in press). An evaluation of a public partnership project between academic institutions and young people with Black African, Asian and Caribbean heritage. Research Involvement and Engagement, 10(1), Article 31. https://doi.org/10.1186/s40900-024-00564-4

Background: This project (named Reinvent) aimed to promote Public Involvement (PI) in health research. Academics worked with a community group, the Eloquent Praise & Empowerment Dance Company, to develop a community partnership with young people from... Read More about An evaluation of a public partnership project between academic institutions and young people with Black African, Asian and Caribbean heritage.

Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases (2024)
Journal Article
Fuller, A., Hancox, J., Williams, H. C., Card, T., Taal, M. W., Aithal, G. P., …Abhishek, A. (2024). Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases. Rheumatology, Article keae175. https://doi.org/10.1093/rheumatology/keae175

To explore the acceptability of an individualised risk-stratified approach to monitoring for target-organ toxicity in adult patients with immune-mediated inflammatory diseases established on immune-suppressing treatment(s). Adults (≥18 years) taking... Read More about Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.